{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:20:41Z","timestamp":1794864041952,"version":"4.9.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012521","name":"Universitas Gadjah Mada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014538","name":"Lembaga Pengelola Dana Pendidikan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014538","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.compbiomed.2025.110757","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T10:14:15Z","timestamp":1752833655000},"page":"110757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"PB","title":["Development of a novel multi-epitope vaccine against triple-negative breast cancer targeting A-kinase anchoring protein 3 using bioinformatics"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1188-2243","authenticated-orcid":false,"given":"Zahrotun","family":"Nafiah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6398-704X","authenticated-orcid":false,"given":"Navista Sri Octa","family":"Ujiantari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badra Sanditya","family":"Rattyananda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3521-6501","authenticated-orcid":false,"given":"Setyowati Triastuti","family":"Utami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratna Surya","family":"Alwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5851-3691","authenticated-orcid":false,"given":"Adam","family":"Hermawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2025.110757_bib1","year":"2023","journal-title":"Breast Cancer"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110757_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/modpathol.2009.145","article-title":"Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer","volume":"23","author":"Thike","year":"2010","journal-title":"Mod. Pathol."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110757_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/modpathol.2010.200","article-title":"Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists","volume":"24","author":"Badve","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.compbiomed.2025.110757_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2014.17322","article-title":"Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States","volume":"313","author":"Iqbal","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.compbiomed.2025.110757_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.15171\/bi.2019.06","article-title":"In silico design of a triple-negative breast cancer vaccine by targeting cancer testis antigens","volume":"9","author":"Parvizpour","year":"2019","journal-title":"Bioimpacts"},{"issue":"20","key":"10.1016\/j.compbiomed.2025.110757_bib7","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-Negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110757_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/PPO.0b013e318233e5b2","article-title":"The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination","volume":"17","author":"Slingluff","year":"2011","journal-title":"Cancer J."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110757_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/annonc\/mdq325","article-title":"Cancer-testis antigen expression in triple-negative breast cancer","volume":"22","author":"Curigliano","year":"2011","journal-title":"Ann. Oncol."},{"issue":"Dec","key":"10.1016\/j.compbiomed.2025.110757_bib10","article-title":"In Silico analysis of synaptonemal complex protein 1 (SYCP1) and acrosin binding protein (ACRBP) antigens to design novel multiepitope peptide cancer vaccine against breast cancer","volume":"25","author":"Safavi","year":"2019","journal-title":"Int. J. Pept. Res. Therapeut."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110757_bib11","first-page":"160","article-title":"Design of a novel recombinant multi-epitope vaccine against triple-negative breast cancer","volume":"26","author":"Dariushnejad","year":"2022","journal-title":"Iran. Biomed. J."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110757_bib12","article-title":"Design and in silico validation of a novel MZF-1-Based multi-epitope vaccine to combat metastatic triple negative breast cancer","volume":"11","author":"Krishnamoorthy","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110757_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12032-023-01970-6","article-title":"Design of a potential Sema4A-based multi-epitope vaccine to combat triple-negative breast cancer: an immunoinformatic approach","volume":"40","author":"Paranthaman","year":"2023","journal-title":"Med. Oncol."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110757_bib14","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s11030-022-10539-w","article-title":"Designing a novel SOX9 based multi-epitope vaccine to combat metastatic triple-negative breast cancer using immunoinformatics approach","volume":"27","author":"Krishnamoorthy","year":"2023","journal-title":"Mol. Divers."},{"issue":"April","key":"10.1016\/j.compbiomed.2025.110757_bib15","article-title":"Structural immunoinformatics approach for rational design of a multi-epitope vaccine against triple negative breast cancer","volume":"243","author":"T","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.compbiomed.2025.110757_bib16","unstructured":"NCI, Double Blind, Parallel Groups, Controlled, Randomized Phase II Trial to Evaluate Vaccination with Folate Receptor Alpha Peptide Vaccine with GM-CSF as Vaccine Adjuvant Following Oral Cyclophosphamide Versus GM-CSF\/Placebo to Prevent Recurrence in Patients with Triple Negative Breast Cancer.."},{"key":"10.1016\/j.compbiomed.2025.110757_bib17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1186\/s12885-015-1668-0","article-title":"AKAP3 correlates with triple negative status and disease-free survival in breast cancer","volume":"15","author":"Esmaeili","year":"2015","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110757_bib18","doi-asserted-by":"crossref","first-page":"8478","DOI":"10.1080\/21655979.2022.2051687","article-title":"The cancer-testis antigen a-kinase anchor protein 3 facilitates breast cancer progression via activation of the PTEN\/PI3K\/AKT\/mTOR signaling","volume":"13","author":"Zhan","year":"2022","journal-title":"Bioengineered"},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110757_bib19","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ni1089","article-title":"Post-proteasomal antigen processing for major histocompatibility complex class I presentation","volume":"5","author":"Rock","year":"2004","journal-title":"Nat. Immunol."},{"issue":"Aug","key":"10.1016\/j.compbiomed.2025.110757_bib20","article-title":"Therapeutic antibodies against intracellular tumor antigens","volume":"8","author":"Trenevska","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.compbiomed.2025.110757_bib21","series-title":"Bioinformatics in Design of Antiviral Vaccines","author":"Nandy","year":"2019"},{"key":"10.1016\/j.compbiomed.2025.110757_bib22","article-title":"Vaccines for African swine fever: an update","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110757_bib23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/08830185.2019.1657426","article-title":"Immunoinformatics: in silico approaches and computational design of a multi-epitope, immunogenic protein","volume":"38","author":"Bahrami","year":"2019","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.compbiomed.2025.110757_bib24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/1471-2105-8-424","article-title":"Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction","volume":"8","author":"V Larsen","year":"2007","journal-title":"BMC Bioinf."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110757_bib25","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1021\/acs.jproteome.9b00874","article-title":"Improved prediction of MHC II antigen presentation through integration and motif deconvolution of mass spectrometry MHC eluted ligand data","volume":"19","author":"Reynisson","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.compbiomed.2025.110757_bib26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fimmu.2017.00292","article-title":"Major Histocompatibility Complex (MHC) class I and MHC class II proteins: conformational plasticity in antigen presentation","volume":"8","author":"Wieczorek","year":"2017","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110757_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B-cell epitopes in an antigen using recurrent neural network","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.compbiomed.2025.110757_bib28","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: a new structure-based tool for the prediction of antibody epitopes","volume":"9","author":"Ponomarenko","year":"2008","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.compbiomed.2025.110757_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinf."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110757_bib30","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v.2--a server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.compbiomed.2025.110757_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1745-6150-8-30","article-title":"Designing of interferon-gamma inducing MHC class-II binders","volume":"8","author":"Dhanda","year":"2013","journal-title":"Biol. Direct"},{"key":"10.1016\/j.compbiomed.2025.110757_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"Bui","year":"2006","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.compbiomed.2025.110757_bib33","series-title":"Protein Identification and Analysis Tools on the Expasy Server BT - the Proteomics Protocols Handbook","first-page":"571","author":"Gasteiger","year":"2005"},{"issue":"Web Server issue","key":"10.1016\/j.compbiomed.2025.110757_bib34","doi-asserted-by":"crossref","first-page":"W349","DOI":"10.1093\/nar\/gkt381","article-title":"Scalable web services for the PSIPRED protein analysis workbench","volume":"41","author":"Buchan","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110757_bib35","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/s41596-022-00728-0","article-title":"I-TASSER-MTD: a deep-learning-based platform for multi-domain protein structure and function prediction","volume":"17","author":"Zhou","year":"2022","journal-title":"Nat. Protoc."},{"issue":"W1","key":"10.1016\/j.compbiomed.2025.110757_bib36","doi-asserted-by":"crossref","first-page":"W294","DOI":"10.1093\/nar\/gks493","article-title":"GalaxyWEB server for protein structure prediction and refinement","volume":"40","author":"Ko","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110757_bib37","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci."},{"key":"10.1016\/j.compbiomed.2025.110757_bib38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.compbiomed.2025.110757_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-1-59745-177-2_19","article-title":"Molecular docking","volume":"443","author":"Morris","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.compbiomed.2025.110757_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145728","article-title":"Landscape of toll-like receptors expression in tumor microenvironment of triple negative breast cancer (TNBC): distinct roles of TLR4 and TLR8","volume":"792","author":"Roychowdhury","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.compbiomed.2025.110757_bib41","series-title":"Toll-Like Receptor 2 at the Crossroad Between Cancer Cells, the Immune System, and the Microbiota","author":"Di Lorenzo","year":"2020"},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110757_bib42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein-protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110757_bib43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/pro.3289","article-title":"PDBsum: structural summaries of PDB entries","volume":"27","author":"Laskowski","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.compbiomed.2025.110757_bib44","series-title":"Design of a Multi-Epitope Vaccine Against Tropheryma whipplei Using Immunoinformatics and Molecular Dynamics Simulation Techniques","author":"Albekairi","year":"2022"},{"issue":"Web Server issue","key":"10.1016\/j.compbiomed.2025.110757_bib45","doi-asserted-by":"crossref","first-page":"W526","DOI":"10.1093\/nar\/gki376","article-title":"JCat: a novel tool to adapt codon usage of a target gene to its potential expression host","volume":"33","author":"Grote","year":"2005","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110757_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009862","article-title":"Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system","volume":"5","author":"Rapin","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110757_bib47","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/sj.bjc.6602022","article-title":"Targeting cytotoxic T lymphocytes for cancer immunotherapy","volume":"91","author":"Maher","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"17","key":"10.1016\/j.compbiomed.2025.110757_bib48","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.vaccine.2018.03.042","article-title":"Immunoinformatics approaches to design a novel multi-epitope subunit vaccine against HIV infection","volume":"36","author":"Pandey","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.compbiomed.2025.110757_bib49","series-title":"The Chemistry and Mechanism of Antibody Binding to Protein Antigens","first-page":"1","author":"Getzoff","year":"1988"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110757_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67749-1","article-title":"A candidate multi-epitope vaccine against SARS-CoV-2","volume":"10","author":"Kar","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110757_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12030376","article-title":"Designing a next-generation multiepitope-based vaccine against Staphylococcus aureus using reverse vaccinology approaches","volume":"12","author":"Mahapatra","year":"2023","journal-title":"Pathogens"},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110757_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104351","article-title":"A potential protein adjuvant derived from Mycobacterium tuberculosis Rv0652 enhances dendritic cells-based tumor immunotherapy","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110757_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01770-w","article-title":"Immunoprotective effect of an in silico designed multiepitope cancer vaccine with BORIS cancer-testis antigen target in a murine mammary carcinoma model","volume":"11","author":"Mahdevar","year":"2021","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110757_bib54","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1080\/07391102.2020.1850357","article-title":"Design of a multi-epitope-based vaccine targeting M-protein of SARS-CoV2: an immunoinformatics approach","volume":"40","author":"Ayyagari","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiomed.2025.110757_bib55","article-title":"In silico vaccine design: a tutorial in immunoinformatics","volume":"2","author":"Martinelli","year":"2022","journal-title":"Healthcare Analy."},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110757_bib56","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.4049\/jimmunol.168.11.5499","article-title":"A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes","volume":"168","author":"Livingston","year":"2002","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110757_bib57","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000445059","article-title":"Design and evaluation of a multi-epitope peptide of human metapneumovirus","volume":"58","author":"Li","year":"2016","journal-title":"Intervirology"},{"issue":"W1","key":"10.1016\/j.compbiomed.2025.110757_bib58","doi-asserted-by":"crossref","first-page":"W174","DOI":"10.1093\/nar\/gkv342","article-title":"I-TASSER server: new development for protein structure and function predictions","volume":"43","author":"Yang","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110757_bib59","article-title":"Brother of Regulator of Imprinted Sites (BORIS) suppresses apoptosis in colorectal cancer","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110757_bib60","article-title":"Folding non-homologous proteins by coupling deep-learning contact maps with I-TASSER assembly simulations","volume":"1","author":"Zheng","year":"2021","journal-title":"Cell Rep. Method."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110757_bib61","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3390\/biom14080983","article-title":"Computational methods to predict conformational B-Cell epitopes","volume":"14","author":"Carroll","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.compbiomed.2025.110757_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6760830","article-title":"An introduction to B-Cell epitope mapping and in silico epitope prediction","volume":"2016","author":"Potocnakova","year":"2016","journal-title":"J. Immunol.Res."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110757_bib63","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/pathogens11020146","article-title":"Machine learning techniques for the prediction of B-Cell and T-Cell epitopes as potential vaccine targets with a specific focus on SARS-CoV-2 pathogen: a review","volume":"11","author":"Bukhari","year":"2022","journal-title":"Pathogens"},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110757_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104351","article-title":"A potential protein adjuvant derived from Mycobacterium tuberculosis Rv0652 enhances dendritic cells-based tumor immunotherapy","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2025.110757_bib65","series-title":"Encyclopedia of Signaling Molecules","first-page":"1","article-title":"TLR4 (Toll-Like receptor 4)","author":"Krishnan","year":"2016"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110757_bib66","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1186\/s12879-024-09881-1","article-title":"Correction: TgVax452, an epitope-based candidate vaccine targeting Toxoplasma gondii tachyzoite-specific SAG1-related sequence (SRS) proteins: immunoinformatics, structural simulations and experimental evidence-based approaches","volume":"24","author":"Majidiani","year":"2024","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110757_bib67","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/21645515.2020.1763693","article-title":"Efficacy of co-immunization with the DNA and peptide vaccines containing SYCP1 and ACRBP epitopes in a murine triple-negative breast cancer model","volume":"17","author":"Safavi","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.compbiomed.2025.110757_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2021.105883","article-title":"Vaccination with rEGVac elicits immunoprotection against different stages of Echinococcus granulosus life cycle: a pilot study","volume":"218","author":"Pourseif","year":"2021","journal-title":"Acta Trop."},{"issue":"30","key":"10.1016\/j.compbiomed.2025.110757_bib69","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1080\/17435889.2024.2419815","article-title":"Design and development of mRNA and self-amplifying mRNA vaccine nanoformulations","volume":"19","author":"Omidi","year":"2024","journal-title":"Nanomedicine"},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110757_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103341","article-title":"Self-amplifying mRNA vaccines: mode of action, design, development and optimization","volume":"27","author":"Pourseif","year":"2022","journal-title":"Drug Discov. Today"}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525011084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525011084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:13:09Z","timestamp":1779509589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482525011084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":69,"alternative-id":["S0010482525011084"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110757","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a novel multi-epitope vaccine against triple-negative breast cancer targeting A-kinase anchoring protein 3 using bioinformatics","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110757"}}